Verve Therapeutics Inc (VERV)

32.16 +0.22  +0.69% NASDAQ Dec 6, 16:00 32.21 +0.05  +0.16% After-Hours: 20:00 USD

Verve Therapeutics Shareholders Equity (Quarterly):

384.94M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Shareholders Equity (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Shareholders Equity (Quarterly) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 384.94M
June 30, 2021 405.40M
March 31, 2021 -76.43M
Dec. 31, 2020 -63.91M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Benchmarks

Krystal Biotech Inc 408.24M
Beam Therapeutics Inc 853.81M
Qualigen Therapeutics Inc 10.85M

Shareholders Equity (Quarterly) Range, Past 5 Years

Minimum -76.43M Mar 2021
Maximum 405.40M Jun 2021
Average 162.50M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 410.88M
Total Liabilities (Quarterly) 25.94M


Insider Buy: Verve Therapeutics
MT Newswires 12/06 12:24 ET
Verve Therapeutics' Q3 Net Loss Shrinks
MT Newswires 11/10 07:51 ET
Top IPO additions to Russell 2000 Index
SA Breaking News 09/17 10:48 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.